ClinicalTrials.Veeva

Menu

Pupil Dilation and Analgesia Nociception Index

V

Vrije Universiteit Brussel

Status

Completed

Conditions

Pain

Treatments

Diagnostic Test: Measurement of pupil dilation and analgesia nociception index

Study type

Interventional

Funder types

Other

Identifiers

NCT03280238
2016/278

Details and patient eligibility

About

Pain assessment is crucial in clinical practice. Currently, subjective self-report is considered the most appropriate method to evaluate pain. Although several methods to assess pain objectively exist, the lack of a golden standard still remains. This pilot study assesses the changes in pupil dilation (PD) and the analgesia nociception index (ANI) as a measure of pain in healthy, conscious, male volunteers in a highly standardized and individualized environment. Nineteen subjects received three blocks of 4 individualized electrical stimulus intensities, ranging from no to severe pain. Subjects reported their perceived severity of each individual stimulus, enabling the comparison of changes in PD and ANI in relation to both administered stimulus intensities and perceived pain severities. PD and ANI were measured before and after each administration of a stimulus.

Enrollment

19 patients

Sex

Male

Ages

18 to 35 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • good health
  • no acute or chronic pain conditions
  • well rested

Exclusion criteria

  • chronic treatment
  • bad health
  • daily use of analgetics or other medication
  • weekly tobacco use
  • weekly use of recreational drugs
  • more than 10 alcohol consumptions a week

Trial design

Primary purpose

Diagnostic

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

19 participants in 1 patient group

Experiment
Experimental group
Description:
* Individualized painful electrical stimuli, Surpass LT stimulator (EMS Biomedical, Korneuburg, Austria) with a bipolar felt pad electrode * Measurement of pupil diameter, Algiscan® (iDMed, Marseille, France) * Measurement of Analgesia Nociception Index, PhysioDoloris® (MetroDoloris, Lille, France)
Treatment:
Diagnostic Test: Measurement of pupil dilation and analgesia nociception index

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems